Decreased nocturnal plasma melatonin peak in patients with estrogen receptor positive breast cancer. 1982

L Tamarkin, and D Danforth, and A Lichter, and E DeMoss, and M Cohen, and B Chabner, and M Lippman

Plasma melatonin concentrations were determined over a period of 24 hours in 20 women with clinical stage I or II breast cancer. In ten of the patients, whose tumors were estrogen receptor positive, the nocturnal increase in plasma melatonin was much lower than that observed in eight control subjects. Women with the lowest peak concentration of melatonin had tumors with the highest concentrations of estrogen receptors. A significant correlation was found between the peak plasma melatonin concentration and the tumor estrogen receptor concentration in 19 of the patients. These data suggest that low nocturnal melatonin concentrations may indicate the presence of estrogen receptor positive breast cancer and could conceivably have etiologic significance.

UI MeSH Term Description Entries
D008550 Melatonin A biogenic amine that is found in animals and plants. In mammals, melatonin is produced by the PINEAL GLAND. Its secretion increases in darkness and decreases during exposure to light. Melatonin is implicated in the regulation of SLEEP, mood, and REPRODUCTION. Melatonin is also an effective antioxidant.
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010870 Pineal Gland A light-sensitive neuroendocrine organ attached to the roof of the THIRD VENTRICLE of the brain. The pineal gland secretes MELATONIN, other BIOGENIC AMINES and NEUROPEPTIDES. Epiphysis Cerebri,Pineal Body,Corpus Pineale,Gland, Pineal,Pineal Bodies,Pineal Glands
D011960 Receptors, Estrogen Cytoplasmic proteins that bind estrogens and migrate to the nucleus where they regulate DNA transcription. Evaluation of the state of estrogen receptors in breast cancer patients has become clinically important. Estrogen Receptor,Estrogen Receptors,Estrogen Nuclear Receptor,Estrogen Receptor Type I,Estrogen Receptor Type II,Estrogen Receptors Type I,Estrogen Receptors Type II,Receptor, Estrogen Nuclear,Receptors, Estrogen, Type I,Receptors, Estrogen, Type II,Nuclear Receptor, Estrogen,Receptor, Estrogen
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D002940 Circadian Rhythm The regular recurrence, in cycles of about 24 hours, of biological processes or activities, such as sensitivity to drugs or environmental and physiological stimuli. Diurnal Rhythm,Nyctohemeral Rhythm,Twenty-Four Hour Rhythm,Nycthemeral Rhythm,Circadian Rhythms,Diurnal Rhythms,Nycthemeral Rhythms,Nyctohemeral Rhythms,Rhythm, Circadian,Rhythm, Diurnal,Rhythm, Nycthemeral,Rhythm, Nyctohemeral,Rhythm, Twenty-Four Hour,Rhythms, Circadian,Rhythms, Diurnal,Rhythms, Nycthemeral,Rhythms, Nyctohemeral,Rhythms, Twenty-Four Hour,Twenty Four Hour Rhythm,Twenty-Four Hour Rhythms
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

L Tamarkin, and D Danforth, and A Lichter, and E DeMoss, and M Cohen, and B Chabner, and M Lippman
September 1986, Neuroscience letters,
L Tamarkin, and D Danforth, and A Lichter, and E DeMoss, and M Cohen, and B Chabner, and M Lippman
January 1993, Life sciences,
L Tamarkin, and D Danforth, and A Lichter, and E DeMoss, and M Cohen, and B Chabner, and M Lippman
April 2017, Journal of the advanced practitioner in oncology,
L Tamarkin, and D Danforth, and A Lichter, and E DeMoss, and M Cohen, and B Chabner, and M Lippman
March 2024, The Journal of surgical research,
L Tamarkin, and D Danforth, and A Lichter, and E DeMoss, and M Cohen, and B Chabner, and M Lippman
January 1990, Oncology,
L Tamarkin, and D Danforth, and A Lichter, and E DeMoss, and M Cohen, and B Chabner, and M Lippman
December 2005, Neuro endocrinology letters,
L Tamarkin, and D Danforth, and A Lichter, and E DeMoss, and M Cohen, and B Chabner, and M Lippman
December 1996, Clinical endocrinology,
L Tamarkin, and D Danforth, and A Lichter, and E DeMoss, and M Cohen, and B Chabner, and M Lippman
March 2019, Obesity surgery,
L Tamarkin, and D Danforth, and A Lichter, and E DeMoss, and M Cohen, and B Chabner, and M Lippman
January 2020, The oncologist,
L Tamarkin, and D Danforth, and A Lichter, and E DeMoss, and M Cohen, and B Chabner, and M Lippman
August 2009, Annals of oncology : official journal of the European Society for Medical Oncology,
Copied contents to your clipboard!